Afghanistan vs Ecuador: New cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Ecuador
100.0%
in 2024
Afghanistan rank
1st
Ecuador rank
1st
New cases tested for RR-/MDR-TB over time
- Afghanistan
- Ecuador
How they compare
Afghanistan currently reports 100.0% against 100.0% in Ecuador, a difference of 0.0%.
Across all 11 years both countries report, Ecuador has been ahead every year.
Afghanistan ranks 1st and Ecuador ranks 1st of 192 countries.
Ecuador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.3% | 20.8% | 14.4% | Ecuador |
| 2020s | 68.8% | 95.8% | 27.0% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Afghanistan or Ecuador?
- Afghanistan, at 100.0% against 100.0% in Ecuador as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Afghanistan and Ecuador?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Ecuador?
- 11 years are reported by both, from 2010 to 2024.
- How do Afghanistan and Ecuador rank globally for new cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Ecuador ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.